Cargando…

Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()

BACKGROUND: Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagatin, Ediléia, Costa, Caroline Sousa, Rocha, Marco Alexandre Dias da, Picosse, Fabíola Rosa, Kamamoto, Cristhine Souza Leão, Pirmez, Rodrigo, Ianhez, Mayra, Miot, Hélio Amante
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772596/
https://www.ncbi.nlm.nih.gov/pubmed/33036809
http://dx.doi.org/10.1016/j.abd.2020.09.001
_version_ 1783629906280710144
author Bagatin, Ediléia
Costa, Caroline Sousa
Rocha, Marco Alexandre Dias da
Picosse, Fabíola Rosa
Kamamoto, Cristhine Souza Leão
Pirmez, Rodrigo
Ianhez, Mayra
Miot, Hélio Amante
author_facet Bagatin, Ediléia
Costa, Caroline Sousa
Rocha, Marco Alexandre Dias da
Picosse, Fabíola Rosa
Kamamoto, Cristhine Souza Leão
Pirmez, Rodrigo
Ianhez, Mayra
Miot, Hélio Amante
author_sort Bagatin, Ediléia
collection PubMed
description BACKGROUND: Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria. OBJECTIVE: To communicate the experience and recommendation of Brazilian dermatologists on oral use of the drug in dermatology. METHODS: Eight experts from five universities were appointed by the Brazilian Society of Dermatology to develop a consensus on indications for this drug. Through the adapted DELPHI methodology, relevant elements were listed and an extensive analysis of the literature was carried out. The consensus was defined with the approval of at least 70% of the experts. RESULTS: With 100% approval from the authors, there was no doubt about the efficacy of oral isotretinoin in the treatment of acne, including as an adjunct in the correction of scars. Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association; they are rare, individual, and should not contraindicate the use of the drug. Regarding unapproved indications, it may represent an option in cases of refractory rosacea, severe seborrheic dermatitis, stabilization of field cancerization with advanced photoaging and, although incipient, frontal fibrosing alopecia. For keratinization disorders, acitretin performs better. In the opinion of the authors, indications for purely esthetic purposes or oil control are not recommended, particularly for women of childbearing age. CONCLUSIONS: Approved and non-approved indications, efficacy and adverse effects of oral isotretinoin in dermatology were presented and critically evaluated.
format Online
Article
Text
id pubmed-7772596
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-77725962020-12-30 Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()() Bagatin, Ediléia Costa, Caroline Sousa Rocha, Marco Alexandre Dias da Picosse, Fabíola Rosa Kamamoto, Cristhine Souza Leão Pirmez, Rodrigo Ianhez, Mayra Miot, Hélio Amante An Bras Dermatol Special Article BACKGROUND: Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria. OBJECTIVE: To communicate the experience and recommendation of Brazilian dermatologists on oral use of the drug in dermatology. METHODS: Eight experts from five universities were appointed by the Brazilian Society of Dermatology to develop a consensus on indications for this drug. Through the adapted DELPHI methodology, relevant elements were listed and an extensive analysis of the literature was carried out. The consensus was defined with the approval of at least 70% of the experts. RESULTS: With 100% approval from the authors, there was no doubt about the efficacy of oral isotretinoin in the treatment of acne, including as an adjunct in the correction of scars. Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association; they are rare, individual, and should not contraindicate the use of the drug. Regarding unapproved indications, it may represent an option in cases of refractory rosacea, severe seborrheic dermatitis, stabilization of field cancerization with advanced photoaging and, although incipient, frontal fibrosing alopecia. For keratinization disorders, acitretin performs better. In the opinion of the authors, indications for purely esthetic purposes or oil control are not recommended, particularly for women of childbearing age. CONCLUSIONS: Approved and non-approved indications, efficacy and adverse effects of oral isotretinoin in dermatology were presented and critically evaluated. Sociedade Brasileira de Dermatologia 2020 2020-10-03 /pmc/articles/PMC7772596/ /pubmed/33036809 http://dx.doi.org/10.1016/j.abd.2020.09.001 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Special Article
Bagatin, Ediléia
Costa, Caroline Sousa
Rocha, Marco Alexandre Dias da
Picosse, Fabíola Rosa
Kamamoto, Cristhine Souza Leão
Pirmez, Rodrigo
Ianhez, Mayra
Miot, Hélio Amante
Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title_full Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title_fullStr Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title_full_unstemmed Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title_short Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
title_sort consensus on the use of oral isotretinoin in dermatology - brazilian society of dermatology()()
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772596/
https://www.ncbi.nlm.nih.gov/pubmed/33036809
http://dx.doi.org/10.1016/j.abd.2020.09.001
work_keys_str_mv AT bagatinedileia consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT costacarolinesousa consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT rochamarcoalexandrediasda consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT picossefabiolarosa consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT kamamotocristhinesouzaleao consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT pirmezrodrigo consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT ianhezmayra consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology
AT miothelioamante consensusontheuseoforalisotretinoinindermatologybraziliansocietyofdermatology